April 16, 2021
Health News

Pfizer-BioNTech COVID-19 vaccine only slightly less effective against key South African mutations: Study – CNA

NEW YORK: Pfizer and BioNTech’s COVID-19 vaccine appeared to only lose a small bit of effectiveness against an engineered virus with three key mutations from the new variant found in South Africa, according to a laboratory study conducted by the US drugmaker.
The study by Pfizer and scientists from the University of Texas Medical Branch (UTMB), which has not yet been peer-reviewed, showed a less than two-fold reduction in antibody titer levels, indicating the vaccine would likely still be effective…

Click here to view the original article.

Related Posts

You might also like ...

Article feature image
We could soon have vaccines for cancer and HIV thanks to COVID-19 vaccine discovery: report – Insider
Article feature image
Three Oregon COVID deaths reported among those vaccinated – KOIN.com
Article feature image
How Epidemiologists Are Planning to Vacation With Their Unvaccinated Kids – Yahoo News